全文获取类型
收费全文 | 35873篇 |
免费 | 2886篇 |
国内免费 | 114篇 |
专业分类
耳鼻咽喉 | 246篇 |
儿科学 | 1150篇 |
妇产科学 | 815篇 |
基础医学 | 5013篇 |
口腔科学 | 592篇 |
临床医学 | 4336篇 |
内科学 | 7579篇 |
皮肤病学 | 717篇 |
神经病学 | 3784篇 |
特种医学 | 691篇 |
外科学 | 3436篇 |
综合类 | 293篇 |
一般理论 | 41篇 |
预防医学 | 4057篇 |
眼科学 | 565篇 |
药学 | 2701篇 |
中国医学 | 54篇 |
肿瘤学 | 2803篇 |
出版年
2023年 | 381篇 |
2022年 | 597篇 |
2021年 | 1276篇 |
2020年 | 775篇 |
2019年 | 1174篇 |
2018年 | 1205篇 |
2017年 | 864篇 |
2016年 | 1017篇 |
2015年 | 1116篇 |
2014年 | 1405篇 |
2013年 | 1813篇 |
2012年 | 2860篇 |
2011年 | 2825篇 |
2010年 | 1506篇 |
2009年 | 1283篇 |
2008年 | 2203篇 |
2007年 | 2261篇 |
2006年 | 2218篇 |
2005年 | 2055篇 |
2004年 | 1907篇 |
2003年 | 1661篇 |
2002年 | 1486篇 |
2001年 | 419篇 |
2000年 | 353篇 |
1999年 | 363篇 |
1998年 | 304篇 |
1997年 | 242篇 |
1996年 | 217篇 |
1995年 | 199篇 |
1994年 | 151篇 |
1993年 | 157篇 |
1992年 | 209篇 |
1991年 | 210篇 |
1990年 | 178篇 |
1989年 | 178篇 |
1988年 | 149篇 |
1987年 | 138篇 |
1986年 | 140篇 |
1985年 | 132篇 |
1984年 | 127篇 |
1983年 | 112篇 |
1982年 | 87篇 |
1981年 | 83篇 |
1980年 | 61篇 |
1979年 | 66篇 |
1978年 | 69篇 |
1976年 | 59篇 |
1974年 | 52篇 |
1973年 | 49篇 |
1972年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Clare Phillips Jasmine Schulkind Margaret OSullivan Natalie Edelman Helen E. Smith Sumita Verma Christina J. Jones 《Journal of viral hepatitis》2020,27(2):176-187
Achieving hepatitis C virus (HCV) elimination by 2030 requires an increased linkage to care for people who inject drugs (PWID). Project ITTREAT was established to mitigate barriers to HCV care by providing an integrated service within a local drug and alcohol treatment centre. This study aimed to explore the experiences of clients and staff involved in Project ITTREAT and assess the facilitators and barriers to a community‐based HCV service. Between October 2014 and April 2016, drug and alcohol treatment attendees were interviewed using one‐to‐one semi‐structured interviews. Drug and alcohol treatment staff took part in focus groups. All data were recorded, transcribed verbatim and analysed using thematic content analysis. Fifteen drug and alcohol treatment attendees with current/previous HCV infection were interviewed, and 15 staff members contributed across two focus groups. Drug and alcohol treatment staff and attendees reported that Project ITTREAT facilitated access to HCV care by mitigating previous negative hospital‐based experiences. Other key facilitators were positive narratives around HCV care, and drug and alcohol treatment attendees being well engaged in their drug/alcohol recovery. Barriers included a lack of stability in drug and alcohol treatment attendees, negative discourse around testing/treatment and stigma associated with attending the drug and alcohol treatment to access HCV treatment in some who had successfully achieved drug rehabilitation. Our findings indicate the positive impact of an integrated and personalized community‐based service delivered by a dedicated hepatitis nurse. This played a crucial role in reducing barriers to HCV care for PWID. Our work also highlights areas for future investment including non–DAT‐based community services and increasing awareness of new treatments amongst this cohort. 相似文献
992.
993.
994.
995.
Angela M. C. Rose Esther Kissling Alin Gherasim Itziar Casado Antonino Bella Odile Launay Mihaela Lazr Sierk Marbus Monika Kuliese Ritva Syrjnen Ausenda Machado Sanja Kure
i Filipovi Amparo Larrauri Jesús Castilla Valeria Alfonsi Florence Galtier Alina Ivanciuc Adam Meijer Aukse Mickiene Niina Ikonen Vernica Gmez Zvjezdana Lovri Makari Alain Moren Marta Valenciano 《Influenza and other respiratory viruses》2020,14(3):302-310
996.
997.
998.
Márcio Galindo Kiuchi MD Shaojie Chen MD PhD Bruno Rustum Andrea MD Tetsuaki Kiuchi MD Maria Angela Magalhães de Queiroz Carreira MD Miguel Luis Graciano MD PhD Jocemir Ronaldo Lugon MD PhD 《Journal of clinical hypertension (Greenwich, Conn.)》2014,16(11):794-800
Twenty‐seven patients with resistant hypertension and chronic kidney disease were treated by renal sympathetic denervation (RSD) and followed for 12 months. Patients were retrospectively divided into controlled and uncontrolled blood pressure (BP) groups. Increases in mean estimated glomerular filtration rate (eGFR) were found at months 1, 3, 6, and 12 in the controlled group (P<.0001, for every time point). The mean change in eGFR after 12 months was 18.54±8.15 mL/min/1.73m2 higher in the controlled group (P=.0318). In patients in the controlled group with baseline eGFR <45 mL/min/1.73 m2, responders (with an increase in eGFR >6.2%) corresponded to 50% at 6 months and 83% at 12 months. In the patients with baseline eGFR ≥45 mL/min/1.73 m2, all patients were labeled as responders at months 6 and 12. Median albumin:creatinine ratio after 12 months was lower than baseline only in the controlled group (P=.0003). Our results suggest that patients with this profile who reached BP control by RSD also experienced a significant improvement in renal function. 相似文献
999.
Nonalcoholic steatohepatitis (NASH) is a frequent cause of cirrhosis and may lead to liver-related mortality. In Western countries, NASH is the most common liver disease and may progress to advanced fibrosis or cirrhosis in a significant portion of cases. Moreover, NASH, even in the absence of cirrhosis, is associated with the development of hepatocellular carcinoma. An increased risk of cardiovascular events and/or diabetes represents another major problem in these patients. In this review, we discuss recent data on the basic mechanisms leading to the development of fibrosis in nonalcoholic steatohepatitis, in particular those which may identify novel approaches to treatment. 相似文献
1000.
C. Barrett Bowling John N. Booth III Orlando M. Gutiérrez Manjula Kurella Tamura Lei Huang Meredith Kilgore Suzanne Judd David G. Warnock William M. McClellan Richard M. Allman Paul Muntner 《Clinical journal of the American Society of Nephrology》2014,9(10):1737-1745